Microbiology

  1. Defining the Syrian hamster as a highly susceptible preclinical model for SARS-CoV-2 infection

    1. Kyle Rosenke
    2. Kimberly Meade-White
    3. Michael Letko
    4. Chad Clancy
    5. Frederick Hansen
    6. Yanan Liu
    7. Atsushi Okumura
    8. Tsing-Lee Tang-Huau
    9. Rong Li
    10. Greg Saturday
    11. Friederike Feldmann
    12. Dana Scott
    13. Zhongde Wang
    14. Vincent Munster
    15. Michael A. Jarvis
    16. Heinz Feldmann

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  2. SARS-CoV-2 entry into human airway organoids is serine protease-mediated and facilitated by the multibasic cleavage site

    1. Anna Z Mykytyn
    2. Tim I Breugem
    3. Samra Riesebosch
    4. Debby Schipper
    5. Petra B van den Doel
    6. Robbert J Rottier
    7. Mart M Lamers
    8. Bart L Haagmans

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  3. Masitinib is a broad coronavirus 3CL inhibitor that blocks replication of SARS-CoV-2

    1. Nir Drayman
    2. Jennifer K. DeMarco
    3. Krysten A. Jones
    4. Saara-Anne Azizi
    5. Heather M. Froggatt
    6. Kemin Tan
    7. Natalia Ivanovna Maltseva
    8. Siquan Chen
    9. Vlad Nicolaescu
    10. Steve Dvorkin
    11. Kevin Furlong
    12. Rahul S. Kathayat
    13. Mason R. Firpo
    14. Vincent Mastrodomenico
    15. Emily A. Bruce
    16. Madaline M. Schmidt
    17. Robert Jedrzejczak
    18. Miguel Á. Muñoz-Alía
    19. Brooke Schuster
    20. Vishnu Nair
    21. Kyu-yeon Han
    22. Amornrat O’Brien
    23. Anastasia Tomatsidou
    24. Bjoern Meyer
    25. Marco Vignuzzi
    26. Dominique Missiakas
    27. Jason W. Botten
    28. Christopher B. Brooke
    29. Hyun Lee
    30. Susan C. Baker
    31. Bryan C. Mounce
    32. Nicholas S. Heaton
    33. William E. Severson
    34. Kenneth E. Palmer
    35. Bryan C. Dickinson
    36. Andrzej Joachimiak
    37. Glenn Randall
    38. Savaş Tay

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  4. Ethacridine inhibits SARS-CoV-2 by inactivating viral particles

    1. Xiaoquan Li
    2. Peter V. Lidsky
    3. Yinghong Xiao
    4. Chien-Ting Wu
    5. Miguel Garcia-Knight
    6. Junjiao Yang
    7. Tsuguhisa Nakayama
    8. Jayakar V. Nayak
    9. Peter K. Jackson
    10. Raul Andino
    11. Xiaokun Shu

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  5. SARS-CoV-2 proteins and anti-COVID-19 drugs induce lytic reactivation of an oncogenic virus

    1. Jungang Chen
    2. Lu Dai
    3. Lindsey Barrett
    4. Jennifer James
    5. Karlie Plaisance-Bonstaff
    6. Steven R. Post
    7. Zhiqiang Qin

    Reviewed by Rapid Reviews Infectious Diseases, ScreenIT

    3 evaluationsAppears in 2 listsLatest version Latest activity

  6. Novel SARS-CoV-2 Whole-genome sequencing technique using Reverse Complement PCR enables easy, fast and accurate outbreak analysis in hospital and community settings

    1. Femke Wolters
    2. Jordy P.M. Coolen
    3. Alma Tostmann
    4. Lenneke F.J. van Groningen
    5. Chantal P. Bleeker-Rovers
    6. Edward C.T.H. Tan
    7. Nannet van der Geest-Blankert
    8. Jeannine L.A. Hautvast
    9. Joost Hopman
    10. Heiman F.L. Wertheim
    11. Janette C. Rahamat-Langendoen
    12. Marko Storch
    13. Willem J.G. Melchers

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  7. Rethinking Remdesivir: Synthesis, Antiviral Activity, and Pharmacokinetics of Oral Lipid Prodrugs

    1. Robert T. Schooley
    2. Aaron F. Carlin
    3. James R. Beadle
    4. Nadejda Valiaeva
    5. Xing-Quan Zhang
    6. Alex E. Clark
    7. Rachel E. McMillan
    8. Sandra L. Leibel
    9. Rachael N. McVicar
    10. Jialei Xie
    11. Aaron F. Garretson
    12. Victoria I. Smith
    13. Joyce Murphy
    14. Karl Y. Hostetler

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  8. Protective Effects of STI-2020 Antibody Delivered Post-Infection by the Intranasal or Intravenous Route in a Syrian Golden Hamster COVID-19 Model

    1. Yanwen Fu
    2. Junki Maruyama
    3. Alok Singh
    4. Reyna Lim
    5. Arthur Ledesma
    6. Daniel Lee
    7. Laura Rivero-Nava
    8. Jamie Ko
    9. Ianne Rivera
    10. Rachel A. Sattler
    11. John T. Manning
    12. Lisa Kerwin
    13. Heyue Zhou
    14. Mark Brunswick
    15. Damien Bresson
    16. Henry Ji
    17. Slobodan Paessler
    18. Robert D. Allen

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  9. The PRRA Insert at the S1/S2 Site Modulates Cellular Tropism of SARS-CoV-2 and ACE2 Usage by the Closely Related Bat RaTG13

    1. Shufeng Liu
    2. Prabhuanand Selvaraj
    3. Christopher Z. Lien
    4. Ivette A. Nunez
    5. Wells W. Wu
    6. Chao-Kai Chou
    7. Tony T. Wang

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  10. Temporal Kinetics of RNAemia and Associated Systemic Cytokines in Hospitalized COVID-19 Patients

    1. Debby van Riel
    2. Carmen W. E. Embregts
    3. Gregorius J. Sips
    4. Johannes P. C. van den Akker
    5. Henrik Endeman
    6. Els van Nood
    7. Mathijs Raadsen
    8. Lisa Bauer
    9. Jeroen van Kampen
    10. Richard Molenkamp
    11. Marion Koopmans
    12. David van de Vijver
    13. Corine H. GeurtsvanKessel

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity
Previous Page 178 of 255 Next